It’s only fair to share… Clesacostat PF 05221304, 752DF9PPPI CAS 1370448-25-1 WeightAverage: 502.571Monoisotopic: 502.221620082 Chemical FormulaC28H30N4O5 4-[6-methoxy-4-(7-oxo-1-propan-2-ylspiro[4,6-dihydroindazole-5,4′-piperidine]-1′-carbonyl)pyridin-2-yl]benzoic acid Clesacostat is under investigation in clinical trial NCT04321031 (Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)). CLESACOSTAT is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has …